Dallas, Texas
Expert witness in healthcare compliance and regulatory matters. Senior paralegal and investigator. Co-founder across FDA-regulated device, pharmacy, surgical hospital, and healthcare services ventures. Practice covers FDA enforcement, HIPAA, the Anti-Kickback Statute, Stark Law, and OIG compliance.
Background
Three decades inside healthcare regulatory disputes, building case strategies, preparing expert analyses for trial, and advising founders and operators across the Dallas–Fort Worth Metroplex and the United States.
Practice covers FDA enforcement, HIPAA privacy and security, the Anti-Kickback Statute, Stark Law physician self-referral prohibitions, and OIG compliance program standards. Cases include regulatory violations, billing fraud, compliance program failures, and healthcare operations disputes. Work with plaintiff and defense counsel on matters where the compliance question is central to liability.
Parallel track as a co-founder and investor across FDA-regulated medical device, pharmacy, surgical hospital, intraoperative neuromonitoring, pharmaceutical wholesale distribution, and healthcare staffing platforms. Multiple exits to strategic acquirers and private equity.
Operational background as senior paralegal and investigator delivers practical knowledge of how compliance failures happen, the documentation gaps that precede enforcement, and the patterns that drive liability. Based in Dallas. Available for retained engagements nationwide.
View on LinkedIn
Practice Focus
351(a) BLA pathway navigation, Drug Master File preparation, pre-IND strategy, and cGMP compliance for biologic therapeutics including cell-derived extracellular vesicle programs.
Commercialization, distribution, physician education, clinical adoption strategy, and revenue model development for advanced cellular and exosome-based therapeutics.
Anti-Kickback Statute analysis, Stark Law advisory, HIPAA frameworks, OIG opinion applications, and corporate practice of medicine structuring across 50-state environments.
Retained expert services for complex healthcare and biotech litigation. Cross-disciplinary testimony spanning clinical operations, regulatory compliance, commercial damages, and industry standards.
Selected Engagements
Late-stage solid tumor program. Non-immunotherapy mechanism designed for refractory disease.
FDA-cleared annular repair technology. Outpatient procedure for chronic discogenic pain.
FDA 510(k) cleared platform. Ownership divested 2021.
Board Tenure & Philanthropy
Texas Scottish Rite Hospital for Children, Dallas.
Multi-year board service alongside his son, Ashton J. Hillman. Co-leader of the annual KidSwing for Scottish Rite golf tournament, a player-fundraising event benefiting pediatric orthopedic care, with personal matched giving across multiple tournament years.
Amounts reflect player-fundraising totals presented at tournament close. Andrew Hillman's contributions included personal matching across the tournament years shown.
Philanthropy
The Andrew Hillman Grant for Biotech is an annual merit-based award recognizing emerging talent in biotechnology, regenerative medicine, and life sciences. Established to support the next generation of researchers, entrepreneurs, and scientists advancing human health.
Recipients are selected on demonstrated innovation, scientific rigor, and the potential for real-world clinical impact. Early-stage support for high-potential individuals produces outsized results for patients and the field.
Selection Criteria
Selected Press
Education & Credentials
Education
Licenses & Certifications
Honors & Affiliations
Programs & Initiatives
Frequently Asked
Andrew Jonathan Hillman is a Dallas-based entrepreneur, investor, and expert witness with three decades of experience in FDA-regulated healthcare ventures. He has co-founded or operated companies in orthobiologics, licensed pharmacy, surgical hospital infrastructure, clinical laboratory services, intraoperative neuromonitoring, and healthcare staffing. He serves as a senior paralegal and investigator at a Dallas private law firm, focused on healthcare compliance and regulatory matters.
The Andrew Hillman Scholarship is an annual award established in 2024 for aspiring entrepreneurs and business leaders across the United States. The program is administered through andrewhillmanscholarship.com.
The Andrew Hillman Grant is a discretionary program supporting biotech and healthcare innovation. Information is available at andrewhillmangrant.com.
Healthcare compliance and regulatory matters including FDA enforcement, the Anti-Kickback Statute, the Stark Law, the Health Insurance Portability and Accountability Act (HIPAA), and matters involving the Office of Inspector General. Engagements include senior paralegal and investigative work across healthcare-regulated industries.
Dallas, Texas. He has practiced from Dallas since 1995.
Southern Methodist University Cox School of Business (1997–2001). Dallas College (1995–1997).
Inquiries are directed to the contact details listed on this site or via the program websites at andrewhillmanscholarship.com and andrewhillmangrant.com.
Andrew Hillman has served on the board of Texas Scottish Rite Hospital for Children in Dallas for many years alongside his son, Ashton J. Hillman. He co-led the annual KidSwing for Scottish Rite Hospital golf tournament with personal matched giving. He is also the founder of the Andrew Hillman Scholarship for entrepreneurs and the Andrew Hillman Grant for biotech innovation.
Inquiries
Serious inquiries regarding advisory, regulatory strategy, or expert witness retention.
Available for retained advisory engagements, expert witness consultations, and strategic partnerships in biotech, healthcare, and legal services. Based in Dallas, Texas.